The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 08, 2019

Filed:

Jul. 18, 2013
Applicant:

Nbe-therapeutics Llc, Basel, CH;

Inventor:

Ulf Grawunder, Basel, CH;

Assignee:
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C12N 1/06 (2006.01); C12N 15/10 (2006.01); C12N 5/10 (2006.01); G01N 33/68 (2006.01); C07K 16/28 (2006.01); C12N 9/12 (2006.01);
U.S. Cl.
CPC ...
C12N 15/1055 (2013.01); C07K 16/28 (2013.01); C12N 5/10 (2013.01); C12N 9/1241 (2013.01); C12N 15/1082 (2013.01); G01N 33/6854 (2013.01); C07K 2317/14 (2013.01); C07K 2317/55 (2013.01); C07K 2317/56 (2013.01); C07K 2317/622 (2013.01);
Abstract

The method disclosed herein describes a novel technology offering unparalleled efficiency, flexibility, utility and speed for the discovery and optimization of polypeptides having desired binding specificity and/or functionality, including antigen-binding molecules such as antibodies and fragments thereof, for desired functional and/or binding phenotypes. The novel method is based on transposable constructs and diverse DNA libraries cloned into transposable vectors and their transfection into host cells by concomitant transient expression of a functional transposase enzyme. This ensures an efficient, stable introduction of the transposon-based expression vectors into vertebrate host cells in one step, which can then be screened for a desired functional or binding phenotype of the expressed proteins, after which the relevant coding sequences for the expressed proteins, including antibodies and fragments thereof, can be identified by standard cloning and DNA sequencing techniques.


Find Patent Forward Citations

Loading…